Sonoma Pharmaceuticals, Inc.
SNOA· Nasdaq
Filed Aug 14, 2013 · 10-Q · 45 days after period end · 0001019687-13-003137
| Metric | Q1 2014 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $3.37M | $2.94M | $2.26M |
| Net Income | -$1.71M | -$2.18M | -$2.38M |
| EPS Diluted | -$0.26 | -$0.08 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 14, 2013 · 45 d after period end